Executive Summary
India's debt securities filings on May 15, 2026, reveal a balanced debt market with one major timely repayment (Grasim's ₹250 Cr CP) signaling strong liquidity, contrasted by new issuances totaling ~₹185 Cr (Mukka ₹75 Cr NCDs, Emkay ₹100 Cr NCDs, Ugro ₹10 Cr CP), indicating ongoing funding needs amid stable operations.
Emkay Global stands out with FY26 revenue up 10.7% YoY to ₹34,898.88 L and Q4 surging 107% YoY, but PAT plunged 79.8% YoY to ₹1,190.14 L due to expenses rising sharply (fees/commission +160% YoY, finance costs +100% YoY), highlighting cost pressures in financial services. Neutral developments include Luxury Time's exemption from large corporate disclosures and RBI's SGB redemption announcement, with no YoY/QoQ trends or insider activity across filings. Portfolio-level patterns show financial firms (Emkay, Ugro) driving issuance volume (110 Cr of 185 Cr), suggesting sector-specific capital demands. Overall, positive repayment sentiment offsets mixed financials, with implications for monitoring redemption timelines and borrowing approvals amid low default risks.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Debt securities
Tracking the trend? Catch up on the prior India Debt Bond Securities SEBI Regulatory Filings digest from May 14, 2026.
Investment Signals (11)
- Grasim Industries ↓ (BULLISH)▲
Full and timely redemption of ₹250 Cr CP (ISIN INE047A14AU4) on May 15, 2026, reducing outstanding to nil, no delays
- Emkay Global ↓ (BULLISH)▲
Revenue from operations +10.7% YoY to ₹34,898.88 L for FY26, Q4 +107% YoY to ₹14,355.66 L driven by fees/commission
- Emkay Global ↓ (BULLISH)▲
Board recommends 15% dividend (₹1.50/share) post FY26 results, signaling confidence despite PAT dip
- Mukka Proteins ↓ (BULLISH)▲
Board approves up to ₹75 Cr secured NCDs (₹25 Cr at 12% coupon/15-month tenure + ₹50 Cr tranches), listed on BSE WDM, secured on current assets
- Ugro Capital ↓ (NEUTRAL-BULLISH)▲
Allotted ₹10 Cr unlisted CP (ISIN INE583D14915) at discount (issue ₹9.71 Cr, redemption ₹10 Cr), 122-day tenure, approved by committee
- Grasim Industries ↓ (BULLISH)▲
Record date April 22, 2026 for CP redemption complied fully per SEBI circular, strong debt servicing track record
- Emkay Global ↓ (BULLISH)▲
Increasing borrowing limits to ₹1,000 Cr subject to approvals, alongside ₹100 Cr NCD raise, proactive capital allocation
- Mukka Proteins ↓ (BULLISH)▲
No prior delays/defaults noted for NCD issuances, senior secured structure enhances creditor confidence
- Luxury Time Ltd ↓ (BULLISH)▲
Confirmed non-Large Corporate status as of Mar 31, 2026 (DIN 00070461), exempt from FY25-26 debt disclosure, reduces regulatory burden
- Emkay Global ↓ (BULLISH)▲
Unmodified auditor opinion on FY26 standalone results per Reg 33/52, CFO declaration confirms
- Ugro Capital ↓ (NEUTRAL-BULLISH)▲
CP issuance via Yes Bank as IPA, short 122-day tenure to Sep 14, 2026 redemption minimizes long-term leverage
Risk Flags (8)
- Emkay Global/Profitability↓ [HIGH RISK]▼
PAT -79.8% YoY to ₹1,190.14 L FY26, Q4 -25.9% to ₹811.82 L due to fees/commission expense +160% YoY to ₹6,952.72 L
- Emkay Global/Finance Costs↓ [MEDIUM RISK]▼
Finance costs doubled YoY to ₹1,751.59 L in FY26, signaling rising debt burden amid revenue growth
- Emkay Global/Overall Sentiment↓ [MEDIUM RISK]▼
Mixed sentiment from strong revenue (Q4 +107% YoY) vs sharp PAT decline, potential margin erosion in financial services
- Ugro Capital/Liquidity↓ [LOW-MEDIUM RISK]▼
New ₹10 Cr CP issuance increases short-term obligations, redemption Sep 14, 2026 at premium (₹10 Cr vs issue ₹9.71 Cr)
- Mukka Proteins/Funding Needs↓ [LOW RISK]▼
Approving ₹75 Cr NCDs indicates potential working capital strain, secured on current assets which may limit flexibility
- Emkay Global/Borrowing Expansion↓ [MEDIUM RISK]▼
Proposed borrowing limit hike to ₹1,000 Cr (from prior levels unspecified), adds leverage risk pending approvals
- RBI SGB/Incomplete Disclosure [LOW RISK]▼
Premature redemption price for SGB 2020-21 Series-VIII (due May 18, 2026) not fully detailed, potential investor uncertainty
- Luxury Time/Regulatory↓ [LOW RISK]▼
Exemption from debt disclosure as non-Large Corporate may obscure full FY25-26 fundraising visibility
Opportunities (8)
- Grasim Industries/Post-Redemption↓ (OPPORTUNITY)◆
Nil CP outstanding post ₹250 Cr repayment frees liquidity for reinvestment, potential for growth initiatives
- Emkay Global/Revenue Momentum↓ (OPPORTUNITY)◆
Q4 revenue +107% YoY to ₹14,355.66 L positions for FY27 recovery despite PAT dip, undervalued entry
- Mukka Proteins/NCD Yield↓ (OPPORTUNITY)◆
12% coupon on ₹25 Cr 15-month NCDs attractive for fixed income investors, secured/listed on BSE WDM
- Emkay Global/Dividend Play↓ (OPPORTUNITY)◆
15% dividend (₹1.50/share) offers yield amid revenue growth, capital raise supports expansion
- Ugro Capital/Short-Tenure CP↓ (OPPORTUNITY)◆
122-day CP at discount provides yield pickup for investors, low duration risk to Sep 14, 2026
- Emkay Global/Capital Raise↓ (OPPORTUNITY)◆
₹100 Cr NCD private placement + borrowing to ₹1,000 Cr enables scaling fees/commission business post +10.7% YoY revenue
- Mukka Proteins/Private Placement↓ (OPPORTUNITY)◆
Up to ₹50 Cr tranches via EBP/non-EBP offers flexible funding at competitive terms, no defaults history
- Luxury Time/Regulatory Relief↓ (OPPORTUNITY)◆
Non-Large Corporate exemption streamlines operations, potential for agile debt strategy without disclosures
Sector Themes (5)
- Timely Debt Repayments (STABLE LIQUIDITY)◆
1/6 filings (Grasim ₹250 Cr CP fully redeemed May 15, 2026) shows robust servicing, positive for corporate debt credibility vs zero delays
- New Issuance Surge in Financials (GROWTH FUNDING)◆
Financial services firms drive 60% of activity (Emkay ₹100 Cr NCDs + Ugro ₹10 Cr CP = ₹110 Cr), signals sector funding for growth amid rising expenses
- Secured NCD/CP Structures (CREDITOR FAVORABLE)◆
3/6 (Mukka, Ugro, implied Emkay) emphasize secured issuances (current assets/pari passu), averaging ~₹62 Cr, reduces default risk
- Mixed Financial Performance (MARGIN PRESSURE)◆
Emkay's +10.7% YoY revenue vs -79.8% PAT highlights cost inflation (expenses +160% YoY), potential theme for NBFCs
- Short-Tenure Instruments (LOW DURATION TREND)◆
Ugro 122-day CP + Mukka 15-month NCDs dominate (avg tenure <18 months), minimizes interest rate risk in rising rate environment
Watch List (7)
-
Monitor Sep 14, 2026 redemption of ₹10 Cr CP (ISIN INE583D14915) for timely servicing post allotment May 15 [Sep 14, 2026]
-
Track approvals for ₹1,000 Cr borrowing limit and ₹100 Cr NCD raise post May 15 board meeting [Pending Q2 2026]
-
Watch for Deemed Date of Allotment and EBP execution for ₹25 Cr/₹50 Cr NCDs, listing on BSE WDM [Near-term May-Jun 2026]
- RBI SGB Series-VIII👁
Full redemption price disclosure for May 18, 2026 premature redemption, impacts gold bond investors [May 18, 2026]
-
Post-FY26 results (PAT -79.8% YoY), monitor earnings call for expense control and revenue outlook [Upcoming Q1 FY27]
-
After ₹250 Cr redemption, watch for refinancing or new issuances per SEBI Master Circular [Q3 2026]
-
Reassess Large Corporate status by Mar 31, 2027 for FY26-27 debt disclosures [Mar 31, 2027]
Filing Analyses
(6)
15-05-2026
Luxury Time Limited confirms that as on March 31, 2026, it does not qualify as a 'Large Corporate' under Para No. 2.2 of SEBI Circular SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021. Consequently, the company is exempt from filing the annual disclosure for fund raising by issuance of debt securities for the Financial Year 2025-26. This intimation is submitted to BSE Limited (Scrip Code: 544635).
- · Scrip Code: 544635
- · DIN: 00070461 (Pawan Chohan)
- · Reference Date for Large Corporate Status: March 31, 2026
15-05-2026
Grasim Industries Limited announced the full and timely repayment of its Commercial Papers (ISIN: INE047A14AU4) on the maturity date of May 15, 2026. The company redeemed 5,000 CP for a total amount of ₹250 crore, resulting in nil outstanding amount. No delays or partial payments were reported.
- · Record date for redemption: April 22, 2026
- · SEBI Master Circular reference: SEBI/HO/DDHS/DDHS-PoD/P/CIR/2025/0000000137 dated October 15, 2025
15-05-2026
The Board of Directors of Mukka Proteins Limited approved the proposed issuance of secured, rated, listed, redeemable non-convertible debentures aggregating up to ₹25,00,00,000 (₹25 Crore) on a private placement basis via EBP with a 12% coupon and 15-month tenure, and up to ₹50,00,00,000 (₹50 Crore) in one or more tranches via EBP or non-EBP. Both issuances are secured on current assets and proposed to be listed on the Wholesale Debt Market Segment of BSE Limited. No prior delays or defaults mentioned.
- · First issuance tenure: 15 months from Deemed Date of Allotment.
- · Debentures are senior, secured, rated, listed, redeemable, taxable, transferable, INR denominated.
- · Security: charge on current assets.
- · No special rights/privileges attached.
- · No delays in payment or defaults reported.
- · Board meeting held on May 15, 2026, from 3:20 p.m. to 3:55 p.m.
15-05-2026
The Board approved audited standalone financial results for FY26, with total revenue from operations growing 10.7% YoY to ₹34,898.88 L amid strong Q4 growth of 107% to ₹14,355.66 L, driven by fees and commission income. However, profit after tax fell sharply 79.8% YoY to ₹1,190.14 L (Q4 down 25.9% to ₹811.82 L) due to elevated expenses including fees and commission expense up 160% to ₹6,952.72 L and finance costs doubling to ₹1,751.59 L. The Board recommended a 15% dividend of ₹1.50 per share, proposed raising up to ₹100 Cr via NCDs on private placement, and increasing borrowing limits to ₹1,000 Cr subject to approvals.
- · Auditor's report issued unmodified opinion on standalone financial results
- · CFO declaration confirming unmodified auditor's opinion per Reg 33(3)(d) and 52(3)(a)
- · Board meeting commenced at 4:00 p.m. and concluded at 5:30 p.m. on May 15, 2026
- · Equity scrip code NSE: EMKAY, BSE: 532737; Debt scrip codes NSE: 976528, BSE: 977388
15-05-2026
Ugro Capital Limited allotted unlisted Commercial Papers to the tune of Rs. 10 Crores on May 15, 2026, with a redemption date of September 14, 2026, and a tenure of 122 days. The face value per security is Rs. 5,00,000, issued at Rs. 4,85,398 per security for a total issue value of Rs. 9,70,79,600, with redemption value of Rs. 10,00,00,000. The Investment and Borrowing Committee approved the allotment, with Yes Bank Limited as the IPA.
- · ISIN: INE583D14915
- · Allotment approved by Investment and Borrowing Committee on May 15, 2026
15-05-2026
RBI announced the redemption price for premature redemption under the Sovereign Gold Bond (SGB) Scheme for SGB 2020-21 Series-VIII, due on May 18, 2026, with the announcement dated May 15, 2026. Specific redemption price and other numerical details are not disclosed in the provided filing excerpt. No corporate financial metrics, changes, or comparisons are mentioned.
- · Announcement sourced from RBI
- · Table details (including full redemption price) incomplete in excerpt
Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 6 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Debt Bond Securities SEBI Regulatory Filings
May 27, 2026
India Debt Bond Securities SEBI Regulatory Filings — May 27, 2026
May 26, 2026
India Debt Bond Securities SEBI Regulatory Filings — May 26, 2026
May 25, 2026
India Debt Bond Securities SEBI Regulatory Filings — May 25, 2026
May 22, 2026
India Debt Bond Securities SEBI Regulatory Filings — May 22, 2026
🇮🇳 More from India
View all →May 28, 2026
India Pre-Market Regulatory Roundup — May 28, 2026
India Pre-Market Regulatory Roundup
May 28, 2026
India Quarterly Results BSE NSE Announcements — May 28, 2026
India Quarterly Results BSE NSE Announcements
May 28, 2026
India Upcoming Corporate Actions BSE NSE — May 28, 2026
India Upcoming Corporate Actions BSE NSE
May 27, 2026
India Pre-Market Regulatory Roundup — May 27, 2026
India Pre-Market Regulatory Roundup